₦ NGN
Language
Currency
‹ All headlines
ScienceDaily Health

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

5 days ago
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go
Download APK
feedback Feedback